EMERGING ANTIMICROBIAL RESISTANCE AND THE IMMUNOCOMPROMISED HOST

被引:27
作者
SHLAES, DM
BINCZEWSKI, B
RICE, LB
机构
[1] Research Service Department of Veterans Affairs Medical Center, Division of Infectious Diseases, Case Western Reserve University School of Medicine, Cleveland, OH
关键词
D O I
10.1093/clinids/17.Supplement_2.S527
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infections caused by gram-positive bacteria have become the most important cause of infectious morbidity among some groups of immunocompromised patients over the last decade. Among the gram-positive bacteria, the emerging problems of resistance to antimicrobial agents include the development of resistance to beta-lactam and aminoglycoside drugs among the enterococci, making synergistic bactericidal therapy impossible; the continued spread of methicillin-resistant staphylococci; resistance to both vancomycin and teicoplanin among enterococci and staphylococci; the emergence of intrinsically vancomycin-resistant species as important pathogens; and resistance to the fluoroquinolones. It is unlikely that new therapeutic classes of antibacterial drugs will be released this decade. Therapeutic alternatives now include unusual combinations of antibiotics to which the strains may appear resistant but that exhibit synergistic activity, although this area has not yet been thoroughly explored. Therefore, control of emergence and spread of resistance through the more judicious use of existing agents, good infection control practices, and the use of imaginative combination therapy for those infected with resistant strains seem to be our best alternatives.
引用
收藏
页码:S527 / S536
页数:10
相关论文
共 109 条
  • [1] COMPARISON OF VANCOMYCIN-INDUCIBLE PROTEINS FROM 4 STRAINS OF ENTEROCOCCI
    ALOBEID, S
    GUTMANN, L
    SHLAES, DM
    WILLIAMSON, R
    COLLATZ, E
    [J]. FEMS MICROBIOLOGY LETTERS, 1990, 70 (01) : 101 - 105
  • [2] REPLACEMENT OF THE ESSENTIAL PENICILLIN-BINDING PROTEIN-5 BY HIGH-MOLECULAR MASS PBPS MAY EXPLAIN VANCOMYCIN BETA-LACTAM SYNERGY IN LOW-LEVEL VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM-D366
    ALOBEID, S
    BILLOTKLEIN, D
    VANHEIJENOORT, J
    COLLATZ, E
    GUTMANN, L
    [J]. FEMS MICROBIOLOGY LETTERS, 1992, 91 (01) : 79 - 84
  • [3] MECHANISM OF RESISTANCE TO VANCOMYCIN IN ENTEROCOCCUS-FAECIUM D366 AND ENTEROCOCCUS-FAECALIS A256
    ALOBEID, S
    COLLATZ, E
    GUTMANN, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) : 252 - 256
  • [4] DETECTION OF METHICILLIN RESISTANCE IN STAPHYLOCOCCI BY USING A DNA PROBE
    ARCHER, GL
    PENNELL, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) : 1720 - 1724
  • [5] STRUCTURAL RELATIONSHIP BETWEEN THE VANCOMYCIN RESISTANCE PROTEIN VANH AND 2-HYDROXYCARBOXYLIC ACID DEHYDROGENASES
    ARTHUR, M
    MOLINAS, C
    DUTKAMALEN, S
    COURVALIN, P
    [J]. GENE, 1991, 103 (01) : 133 - 134
  • [6] EVIDENCE FOR INVIVO INCORPORATION OF D-LACTATE INTO PEPTIDOGLYCAN PRECURSORS OF VANCOMYCIN-RESISTANT ENTEROCOCCI
    ARTHUR, M
    MOLINAS, C
    BUGG, TDH
    WRIGHT, GD
    WALSH, CT
    COURVALIN, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) : 867 - 869
  • [8] STREPTOCOCCAL AND ENTEROCOCCAL BACTEREMIA IN PATIENTS WITH CANCER
    AWADA, A
    VANDERAUWERA, P
    MEUNIER, F
    DANEAU, D
    KLASTERSKY, J
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) : 33 - 48
  • [9] BARBER M, 1948, LANCET, V2, P641
  • [10] THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUP
    BARNA, JCJ
    WILLIAMS, DH
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 1984, 38 : 339 - 357